News
About GRI Bio, Inc. GRI Bio is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio’s therapies are ...
today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) ...
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results